|
|
|
|
LEADER |
00000cam a2200000Mi 4500 |
001 |
EBOOKCENTRAL_ocn437176652 |
003 |
OCoLC |
005 |
20240329122006.0 |
006 |
m o d |
007 |
cr mn|---||||| |
008 |
090817s2006 sz o 000 0 eng d |
040 |
|
|
|a MERUC
|b eng
|e pn
|c MERUC
|d EBLCP
|d OCLCQ
|d DEBSZ
|d OCLCQ
|d VZF
|d OCLCO
|d YDXCP
|d OCLCF
|d OCLCQ
|d OCLCO
|d OCLCQ
|d ZCU
|d MERUC
|d OCLCQ
|d ICG
|d OCLCQ
|d DKC
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCL
|
019 |
|
|
|a 476039192
|a 905107597
|
020 |
|
|
|a 9789240682108
|q (electronic bk.)
|
020 |
|
|
|a 9240682104
|q (electronic bk.)
|
029 |
1 |
|
|a AU@
|b 000048750754
|
029 |
1 |
|
|a DEBBG
|b BV044122887
|
029 |
1 |
|
|a DEBSZ
|b 396108369
|
029 |
1 |
|
|a AU@
|b 000069300611
|
035 |
|
|
|a (OCoLC)437176652
|z (OCoLC)476039192
|z (OCoLC)905107597
|
050 |
|
4 |
|a QV32.1 W628 no.942
|a RA8 .A25 no.942
|
082 |
0 |
4 |
|a 300
|a 500
|
049 |
|
|
|a UAMI
|
100 |
1 |
|
|a Organization, World Health.
|
245 |
1 |
0 |
|a WHO Expert Committee on Drug Dependence :
|b Thirty-fourth Report Technical Report Series, No 942.
|
260 |
|
|
|a Geneva :
|b World Health Organization,
|c 2006.
|
300 |
|
|
|a 1 online resource (36 pages)
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
505 |
0 |
|
|a Preliminaries; Contents; 1 Introduction; 2 Critical review of psychoactive substances; 3 Pre review of psychoactive substances; 4 Substances identifi ed for future pre review; 5 Guidelines for the WHO review of dependence producing psychoactive substances for international control; 6 Other matters; Acknowledgements; References.
|
520 |
|
|
|a This report presents the recommendations of a WHO Expert Committee responsible for reviewing information on dependence-producing drugs to assess the need for their international control. The first part of the report contains a summary of the Committee's evaluations of seven substances (dronabinol, oripavine, buprenorphine, butorphanol, ketamine, khat and zopiclone). The report also discusses the substances that were pre-reviewed (gamma-hydroxybutyric acid and tramadol) and recommended gamma-hydroxybutyric acid for critical review at a future meeting. Two substances (gamma-butyrolactone and 1,4.
|
588 |
0 |
|
|a Print version record.
|
590 |
|
|
|a ProQuest Ebook Central
|b Ebook Central Academic Complete
|
650 |
|
0 |
|a Psychotropic drugs.
|
650 |
|
2 |
|a Psychotropic Drugs
|
650 |
|
6 |
|a Psychotropes.
|
650 |
|
7 |
|a Psychotropic drugs
|2 fast
|
758 |
|
|
|i has work:
|a WHO Expert Committee on Drug Dependence (Text)
|1 https://id.oclc.org/worldcat/entity/E39PD3bgtBRvYhpfYkb6CXY4C3
|4 https://id.oclc.org/worldcat/ontology/hasWork
|
776 |
1 |
|
|z 9789241209427
|
856 |
4 |
0 |
|u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=286858
|z Texto completo
|
938 |
|
|
|a EBL - Ebook Library
|b EBLB
|n EBL286858
|
938 |
|
|
|a YBP Library Services
|b YANK
|n 2551880
|
994 |
|
|
|a 92
|b IZTAP
|